ADPT - Adaptive Biotechnologies Corp


14.04
-0.170   -1.211%

Share volume: 1,229,374
Last Updated: 04-28-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.20%

PREVIOUS CLOSE
CHG
CHG%

$14.21
-0.17
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-07-2024 08-01-2024 11-07-2024 03-03-2025 05-01-2025 08-05-2025 11-05-2025 02-26-2026
Total revenue 41.873 M 43.190 M 46.435 M 47.459 M 52.443 M 58.879 M 93.973 M 71.681 M
Cost of revenue 18.051 M 19.317 M 16.667 M 18.045 M 16.979 M 17.999 M 18.157 M 18.224 M
Gross profit 23.822 M 23.873 M 29.768 M 29.414 M 35.464 M 40.880 M 75.816 M 53.457 M
    0.21% 24.69% -1.19% 20.57% 15.27% 85.46% -29.49%  
Operating expenses 49.842 M 43.248 M 41.421 M 41.248 M 41.602 M 41.920 M 41.628 M 41.320 M
Selling general and admin 19.597 M 17.895 M 17.258 M 18.056 M 17.399 M 17.786 M 17.959 M 19.557 M
Research and development 30.245 M 25.353 M 24.163 M 23.192 M 24.203 M 24.134 M 23.669 M 21.763 M
Total expenses 72.584 M 71.191 M 62.400 M 63.251 M 65.068 M 65.916 M 65.526 M 66.230 M
    -1.92% -12.35% 1.36% 2.87% 1.30% -0.59% 1.07%  
Operating income -48.762 M -47.318 M -32.632 M -33.837 M -29.604 M -25.036 M 10.290 M -12.773 M
Ebit -48.762 M -47.318 M -32.632 M -33.837 M -29.604 M -25.036 M 10.290 M -12.773 M
Pretax income -47.533 M -46.248 M -32.097 M -33.717 M -29.830 M -25.593 M 9.545 M -13.579 M
    -2.70% -30.60% 5.05% -11.53% -14.20% -137.30% -242.26%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income -47.533 M -46.248 M -32.097 M -33.717 M -29.830 M -25.593 M 9.545 M -13.579 M
    2.70% 30.60% -5.05% 11.53% 14.20% 137.30% -242.26%